THOUSAND OAKS, Calif., Jan 09, 2006 (BUSINESS WIRE) -- Amgen (Nasdaq:AMGN), the world´s largest biotechnology
company, today announced plans to report 2005 fourth quarter and full
year financial results on Thursday, January 26, 2006, before the
opening of the financial markets. The announcement will be followed by
a live conference with the investment community at 8 a.m. Eastern
Participating in the event from Amgen will be Kevin Sharer,
chairman and chief executive officer, and other members of Amgen´s
senior management team.
The conference will be simultaneously broadcast over the Internet
and will be available to members of the news media, investors and the
general public. The event, including the question and answer session,
is expected to last approximately two hours.
The webcast of the conference can be found on www.amgen.com by
clicking on Investors. A link to the webcast is under the Events
header. The webcast will be archived and available for replay 72 hours
after the event.
Amgen discovers, develops and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the
first companies to realize the new science´s promise by bringing safe
and effective medicines from lab, to manufacturing plant, to patient.
Amgen therapeutics have changed the practice of medicine, helping
millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses.
With a broad and deep pipeline of potential new medicines, Amgen
remains committed to advancing science to dramatically improve
people´s lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
Amgen, Thousand Oaks
Christine Cassiano, 805-447-4587 (media)
Arvind Sood, 805-447-1060 (investors)